P&G's Q2 Earnings Burdened By Rising Costs, But Respite In Sight
This article was originally published in The Rose Sheet
Executive Summary
Procter & Gamble expects commodity costs to drop over the next two quarters, but for the firm’s FY 2012 second quarter, they contributed to a 49% decline in earnings to $1.69 billion.
You may also be interested in...
P&G Targets $10 Billion In Cost Savings In Four Years
P&G will $10 billion in costs by the end of fiscal 2016, firm says at Analyst Group of New York Conference Feb. 23. Firm aims to derive $3 billion of that from reduced overhead, with plans to cut 5,700 jobs by the end of next fiscal year.
P&G To Hike Prices At Least 3%, Expects Others To Follow
Procter & Gamble expects that an across-the-board price increase of at least 3% – spurred by higher commodity costs – will prompt its competitors to raise product prices as well.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”